Zoledronic acid prevents pagetic-like lesions and accelerated bone loss in the p62P394Lmouse model of Paget's disease

Long-Term Randomized Trial of Intensive Versus Symptomatic Management in Paget's Disease of Bone: The PRISM-EZ Study

(2017) Adrian Tan et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Targeting cellular senescence prevents age-related bone loss in mice

(2017) Joshua N Farr et al.   NATURE MEDICINE

Durability of Response to Zoledronate Treatment and Competing Mortality in Paget's Disease of Bone

(2016) Tim Cundy et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Evolution of Paget's disease of bone in adults inheritingSQSTM1mutations

(2015) Tim Cundy et al.   CLINICAL ENDOCRINOLOGY

Effect of Age on Regulation of Human Osteoclast Differentiation

(2014) Ping-Lin Chung et al.   JOURNAL OF CELLULAR BIOCHEMISTRY

Epidemiology of Paget's disease of bone: A systematic review and meta-analysis of secular changes

(2013) Luis Corral-Gudino et al.   BONE

New Insights Into the Role of Sequestosome 1/p62 Mutant Proteins in the Pathogenesis of Paget's Disease of Bone

(2013) Sarah L. Rea et al.   ENDOCRINE REVIEWS

Common susceptibility alleles andSQSTM1mutations predict disease extent and severity in a multinational study of patients with Paget's disease

(2013) Omar ME Albagha et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Autophagy Proteins Regulate the Secretory Component of Osteoclastic Bone Resorption

(2011) Carl J. DeSelm et al.   DEVELOPMENTAL CELL

A point mutation in the ubiquitin-associated domain of SQSMT1 is sufficient to cause a Paget's disease-like disorder in mice

(2011) Anna Daroszewska et al.   HUMAN MOLECULAR GENETICS

Bisphosphonate Use and Atypical Fractures of the Femoral Shaft

(2011) Jörg Schilcher et al.   NEW ENGLAND JOURNAL OF MEDICINE

Pathophysiology of atypical femoral fractures and osteonecrosis of the jaw

(2011) J. Compston   OSTEOPOROSIS INTERNATIONAL

Bisphosphonates in Paget's disease

(2010) Ian R. Reid et al.   BONE

Bisphosphonate effects on bone turnover, microdamage, and mechanical properties: What we think we know and what we know that we don't know

(2010) Matthew R. Allen et al.   BONE

Genome-wide association study identifies variants at CSF1, OPTN and TNFRSF11A as genetic risk factors for Paget's disease of bone

(2010) Omar M E Albagha et al.   NATURE GENETICS

Randomized trial of intensive bisphosphonate treatment versus symptomatic management in paget's disease of bone

(2009) Anne L Langston et al.   JOURNAL OF BONE AND MINERAL RESEARCH

The p62 P392L Mutation Linked to Paget’s Disease Induces Activation of Human Osteoclasts

(2009) Estelle Chamoux et al.   MOLECULAR ENDOCRINOLOGY

Aminobisphosphonates Cause Osteoblast Apoptosis and Inhibit Bone Nodule Formation In Vitro

(2008) Aymen I. Idris et al.   CALCIFIED TISSUE INTERNATIONAL

A SQSTM1/p62 mutation linked to Paget’s disease increases the osteoclastogenic potential of the bone microenvironment

(2008) Yuko Hiruma et al.   HUMAN MOLECULAR GENETICS

Apoptotic Bodies Convey Activity Capable of Initiating Osteoclastogenesis and Localized Bone Destruction

(2008) Giolanta Kogianni et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Osteocyte Apoptosis Controls Activation of Intracortical Resorption in Response to Bone Fatigue

(2008) Luis Cardoso et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Pathogenesis and management of Paget's disease of bone

(2008) Stuart H Ralston et al.   LANCET